Patient Preferences, Analgesic Delivery Method and Pain Reduction in Spine Patients

Western Galilee Hospital-Nahariya

Status: Withdrawn

Conditions: Pain Relief

Treatments: Drug: Diclofenac hydroxyethylpyrrolidine; Drug: Tramadol; Drug: Dipyrone; Drug: orphenadrine

Study type: Interventional

Funder types: Other

Identifiers

NCT01263652

SpinePainIMPO

Details and patient eligibility

About

The investigators will conduct a randomized double blind study, to determine whether patient analgesic delivery mode preference affects pain reduction quality in non-surgical spine patients.

The patients will receive both intra-muscular and oral non-narcotic analgesics and placebo. During the study period, pain reduction parameters will be collected. At the end of the study period, the investigators will attempt to find a correlation between pre-study patient preferences and the quality of the pain reduction achieved.

Sex: All

Ages: 15 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with chronic and acute back pain

Exclusion criteria

• Recent Spine Surgery

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

0 participants in 2 patient groups

IMmed

Active Comparator group

Description:

Patients receiving intra-muscular medication and oral placebo

Treatment:

Drug: orphenadrine

Drug: Dipyrone

Drug: Tramadol

Drug: Diclofenac hydroxyethylpyrrolidine

POmed

Active Comparator group

Description:

Patients receiving intra-muscular placebo and oral medication

Treatment:

Drug: orphenadrine

Drug: Dipyrone

Drug: Tramadol

Drug: Diclofenac hydroxyethylpyrrolidine